Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis

INTRODUCTION: Differences in class or molecule-specific effects between renin–angiotensin–aldosterone system (RAAS) inhibitors have not been conclusively demonstrated. This study used South African data to assess clinical and cost outcomes of antihypertensive therapy with the three most common RAAS...

Descripción completa

Detalles Bibliográficos
Autores principales: Snyman, Jacques R., Gumedze, Freedom, Jones, Erika S. W., Alaba, Olufunke A., Tsabedze, Nqoba, Vira, Alykhan, Ntusi, Ntobeko A. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567948/
https://www.ncbi.nlm.nih.gov/pubmed/37730949
http://dx.doi.org/10.1007/s12325-023-02641-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567948/
https://www.ncbi.nlm.nih.gov/pubmed/37730949
http://dx.doi.org/10.1007/s12325-023-02641-8

Ejemplares similares